PRESS RELEASE

FOR IMMEDIATE RELEASE

CONTACT

Invitro International

Contact: W. Richard Ulmer

17751 Sky Park East, Suite G

(800) 2-INVITRO

Irvine, CA 92614

http://www.invitrointl.com


INVITRO INTERNATIONAL POSTS FY '05
PROFIT ON SOLID SALES GAIN


Irvine, CA February 6, 2006- InVitro International (OTC, Pink Sheets, IVRO) today reported a 12% sales gain for Fiscal Year '05 vs. Fiscal Year '04, to $671,068. IVRO also recorded net profit of $14,655 compared to a loss of $34,614 last year. IVRO President, W. Richard Ulmer said: "We felt very encouraged about our financial progress in '05: sales reached their highest level in 8 years, and we earned a small profit while investing in new assay technology. Our non-animal testing methods are being more accepted globally because they're faster, less expensive, easier to use, and can be kept on the shelf for later use when convenient. Meanwhile we continue to work for European Regulatory Acceptance well ahead of the 2009 marketing ban on new cosmetics if tested on animals."

This press release may contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties. These risks and uncertainties include, but are not limited to: acceptance of the Company's technology by customers or regulatory agencies, changes in market conditions and other competitive factors. Any such forward-looking statements are not guarantees of future performance.


CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

 

Three months ended
September 30

Twelve months ended
September 30

 

2005

2004

2005

2004

Revenues

183,477

125,811

671,068

596,123

Costs and expenses

216,569

167,835

660,463

632,298

Income (loss) from operations

(33,092)

(42,023)

10,605

(36,175)

Other income (loss)

997

9,677

4,050

1,561

Net profit (loss)

(32,095)

(32,346)

14,655

(34,614)

Profit (loss) per common share

(0.002)

(0.002)

0.001

(0.002)

Weighted average common
shares outstanding

16,824,809

15,836,562

16,824,809

15,836,562

 


CONDENSED CONSOLIDATED BALANCE SHEET

 

 

 

September 30, 2005

September 30, 2004

Cash, cash equivalents and marketable securities

158,694

124,922

Other current assets

 

 

207,444

201,927

Total current assets

 

 

366,138

326,849

Noncurrent assets

 

 

38,881

38,596

Total assets

 

 

405,019

365,445

Current liabilities

 

 

48,921

24,002

Shareholders' equity

 

 

356,098

341,443

Total liabilities and equity

 

 

405,019

365,445


# # #

InVitro International
17751 Sky Park East, Suite G
Irvine, CA 92614

800-2-INVITRO (800-246-8487)
949-851-8356 (International callers)
949- 851-4985 Fax

invitro@invitrointl.com

pink sheets quote
Stock Quote, Chart, News

 

 

Recent News
SEE PRESS RELEASES FOR MOST RECENT NEWS
 
Order Products Directly!

Purchase Corrositex Database Test Results Online!

 

 

Corrositex Instruction Manual

This manual is password Protected. Please contact InVitro International
in Irvine, CA. for a password.